| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 |
| filingDate |
2003-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d702e3b18413f2b5bded48a4eb2175f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4bb6c22d9b6c8c5ab3926f98ba512aa |
| publicationDate |
2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005020591-A1 |
| titleOfInvention |
2-Quinoxalinone derivatives as bradykinin antagonists and novel compounds |
| abstract |
2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10428030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006111392-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018159805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007067629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039846-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2895204-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009520013-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104780944-A |
| priorityDate |
2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |